A Therapy-Resistant Chronic Leg Ulcer Treated Successfully with Topical Basic Fibroblast Growth Factor
Authors:
- 1 April 2003
- journal article
- case report
- Published by SAGE Publications in Journal of International Medical Research
- Vol. 31 (2) , 149-151
Abstract
We report a patient with rheumatoid arthritis who had a chronic leg ulcer with long-standing resistance to therapy. Topical basic fibroblast growth factor (bFGF) at a dose of 30 μg/day for 3 months was clinically effective in reducing the ulcer area by promoting angiogenesis, re-epithelization, granulation and scar formation. bFGF may be an effective treatment for therapy-resistant leg ulcers.Keywords
This publication has 5 references indexed in Scilit:
- Cutaneous Wound HealingNew England Journal of Medicine, 1999
- Stimulation of Growth of Keratinocytes by Basic Fibroblast Growth FactorJournal of Investigative Dermatology, 1988
- Basic fibroblast growth factor induces angiogenesis in vitro.Proceedings of the National Academy of Sciences, 1986
- Quantitation of rheumatoid factor by laser nephelometryRheumatology International, 1982
- Localisation of a fibroblast growth factor and its effect alone and with hydrocortisone on 3T3 cell growthNature, 1974